C4 therapeutics to participate in the stifel 2023 virtual targeted oncology days

Watertown, mass., april 19, 2023 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that c4t management will participate in a fireside chat at the stifel 2023 virtual targeted oncology days.
CCCC Ratings Summary
CCCC Quant Ranking